She was diagnosed with Parkinson’s at 27. These were her warning signs.
People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.
Sergey Brin’s $2 Billion Quest To Tackle Parkinson’s, Bipolar Disorder And Now Autism
The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...
The American Journal of Managed Care3d
FDA Approves First Subcutaneous Apomorphine Device for Parkinson Disease
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
Can mold exposure cause Parkinson’s disease? Colorado Springs family hopes to prove “landmark” legal case
A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month ...
The News & Advance2d
Inspired by father, Lynchburg woman runs for Parkinson's
Taryn Robertson, a professor at Randolph College, is currently fundraising and training to run a marathon for her father who ...
Northern Virginia Daily9d
Exercise class helps Parkinson's patients manage their symptoms
Patients living with Parkinson’s disease are encouraged to engage in regular exercise to help manage symptoms and improve ...
Knowridge21h
Research shows major causes of Parkinson’s disease and dementia
Parkinson’s disease is a brain disorder that affects movement, making everyday tasks difficult for nearly one million people ...
Grammy-winning singer, Cleveland native reveals Parkinson’s diagnosis
Marc Cohn, a Cleveland native and a Grammy Award-winning singer best known for his hit "Walking in Memphis," revealed he was ...
Red flags of Parkinson's disease as mum is diagnosed at just 28 years old
Nicole LaBolle initially dismissed her shaking as something fairly common before facing a Parkinson's diagnosis at 28 ...
Parkinson's Disease Psychosis Market Poised For Significant Growth By 2034, Predicts Delveinsight
DelveInsight's Parkinson's disease Psychosis market Report provides comprehensive insights into the epidemiology and market dynamics across the 7MM. LAS VEGAS , NV, UNITED STATES, January 30, 2025 ...
Becker's Hospital Review2d
GLP-1 drug fails to slow Parkinson's: Study
A final-stage study has found that exenatide, a GLP-1 drug used to treat Type 2 diabetes, showed no benefit in slowing the progression of Parkinson's disease. The 96-week trial, published in The ...